Entyvio (vedolizumab)

pCPA File Number: 20913

Negotiation Status:

Concluded with an LOI

Indication(s):

Ulcerative Colitis

Sponsor/Manufacturer:

Takeda Canada Inc.

CDA-AMC Project Number:

SR0421-000

pCPA Engagement Letter Issued:

2016-05-26

Negotiation Process Concluded:

2017-03-03